Analytical Data
-
Gene name
IGLC2
- Application
-
Alternative Names
Immunoglobulin lambda constant 2. Ig lambda chain C region Kern. Ig lambda chain C region NIG-64. Ig lambda chain C region SH. Ig lambda chain C region X. Ig lambda-2 chain C region
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0DOY2
-
Expression Region
1-235aa
-
AA Sequence
MASFPLLLTLLTHCAGSWAQSVLTQPPSASGTPGQRVPISCSGSSSNIGSNTVNWYQQFPGTAPKLLIYSNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDDAVYHCATWDDNLNSWVFGGGTKLTVLSQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTECS
-
Molecular Weight
51.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of IGLC2 recombinant proteins has gained significant attention within the field of immunology due to their crucial role in the immune response. IGLC2 is a member of the immunoglobulin lambda chain gene family, encoding the light chain of certain antibodies. Understanding the structure and function of IGLC2 is essential for both fundamental research and potential therapeutic applications. Recent advancements in recombinant DNA technology have enabled the production of IGLC2 proteins in host systems, allowing for detailed characterization of their biological properties. These recombinant proteins can be used in various applications, including the development of novel diagnostic tools and therapeutic agents for diseases where immune dysfunction is a factor, such as autoimmune disorders and cancers. Furthermore, the exploration of IGLC2 in the context of monoclonal antibody production offers insights into the generation of more effective and targeted immunotherapies. Continued research on IGLC2 recombinant proteins could lead to innovations in immune modulation strategies and a deeper understanding of antibody diversity and function.
